These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 30853415)
21. Different predictive values of interim Kim J; Lee JO; Paik JH; Lee WW; Kim SE; Song YS Ann Nucl Med; 2017 Jan; 31(1):1-11. PubMed ID: 27627889 [TBL] [Abstract][Full Text] [Related]
22. 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer. De Leiris N; Riou L; Leenhardt J; Vuillez JP; Djaileb L Clin Nucl Med; 2018 Dec; 43(12):e471-e472. PubMed ID: 30300202 [TBL] [Abstract][Full Text] [Related]
23. 18F-FDG PET/CT diagnosis of vagus nerve neurolymphomatosis. Tsang HH; Lee EY; Anthony MP; Khong PL Clin Nucl Med; 2012 Sep; 37(9):897-8. PubMed ID: 22889783 [TBL] [Abstract][Full Text] [Related]
24. [A case of neurolymphomatosis]. Gelezhe PB; Medvedeva AV Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8):150-153. PubMed ID: 36036417 [TBL] [Abstract][Full Text] [Related]
25. Use of FDG PET/CT in identification of bone marrow involvement in diffuse large B cell lymphoma and follicular lymphoma: comparison with iliac crest bone marrow biopsy. Teagle AR; Barton H; Charles-Edwards E; Dizdarevic S; Chevassut T Acta Radiol; 2017 Dec; 58(12):1476-1484. PubMed ID: 28382828 [TBL] [Abstract][Full Text] [Related]
26. Costs and clinical outcomes of patients with diffuse large B-cell lymphoma in first remission: role of PET/CT surveillance. Suh KJ; Kim KH; Kim R; Byun JM; Kim M; Park JH; Keam B; Kim TM; Kim JS; Choi IS; Heo DS Korean J Intern Med; 2019 Jul; 34(4):894-901. PubMed ID: 29466847 [TBL] [Abstract][Full Text] [Related]
27. Bottle brush sign by De Bonilla-Candau M; Moreno-Ballesteros A; Tortajada-Bustelo CJ; Cardozo-Saavedra A; Aguadé-Bruix S Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(4):279-280. PubMed ID: 37269982 [No Abstract] [Full Text] [Related]
28. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma. Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697 [TBL] [Abstract][Full Text] [Related]
29. Central Nervous System Involvement of Intravascular Large B-Cell Lymphoma on 18F-FDG PET/CT. Higashiyama A; Komori T; Inada Y; Nakajima H; Narumi Y Clin Nucl Med; 2017 May; 42(5):e258-e260. PubMed ID: 28166145 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases. Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845 [TBL] [Abstract][Full Text] [Related]
31. Unusually Elevated Gastric Radioactivity on 18F-FDG PET/CT in Diffuse Large B-Cell Lymphoma. Yin H; Liu G; Xiu Y; Luo R; Shi H Clin Nucl Med; 2018 Jul; 43(7):512-514. PubMed ID: 29561528 [TBL] [Abstract][Full Text] [Related]
32. Unexpected Corpus Callosum Involvement of Diffuse Large B-Cell Lymphoma on FDG PET/CT. Kan Y; Wang Y; Wang W; Liu J; Yang J Clin Nucl Med; 2018 Dec; 43(12):933-935. PubMed ID: 30325829 [TBL] [Abstract][Full Text] [Related]
33. An unusual case of diffuse large B-cell lymphoma involving the vulva evaluated by 18F-FDG PET/CT. Treglia G; Paone G; Perriard U; Ceriani L; Giovanella L Clin Nucl Med; 2014 Oct; 39(10):e439-41. PubMed ID: 24152653 [TBL] [Abstract][Full Text] [Related]
34. Follicular lymphoma transforming into diffuse large B-cell lymphoma in spleen: Simultaneous appearance of both on Makis W; Ciarallo A; Petrogiannis-Haliotis T; Rosenberg A; Probst S Clin Imaging; 2017; 43():88-92. PubMed ID: 28259031 [TBL] [Abstract][Full Text] [Related]
35. Sciatic and median nerve neurolymphomatosis as initial presentation of B-cell lymphoma. Barahona D; Adlerstein I; Donoso J; Mercado F Radiologia (Engl Ed); 2022; 64(3):266-269. PubMed ID: 35676058 [TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of metabolic tumor burden by positron emission tomography/computed tomography in patients with relapsed/refractory diffuse large B-cell lymphoma. Tateishi U; Tatsumi M; Terauchi T; Ando K; Niitsu N; Kim WS; Suh C; Ogura M; Tobinai K Cancer Sci; 2015 Feb; 106(2):186-93. PubMed ID: 25495273 [TBL] [Abstract][Full Text] [Related]
37. End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma. Kostakoglu L; Nowakowski GS PET Clin; 2019 Jul; 14(3):307-315. PubMed ID: 31084771 [TBL] [Abstract][Full Text] [Related]
38. Prognostic analysis of interim Yuan L; Kreissl MC; Su L; Wu Z; Hacker M; Liu J; Zhang X; Bo Y; Zhang H; Li X; Li S Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):478-488. PubMed ID: 30382301 [TBL] [Abstract][Full Text] [Related]
39. Pretherapy and posttherapy 18F-FDG PET/CT in isolated nasoseptal diffuse large B-cell lymphoma. Asa S; Aliyev A; Yılmaz S; Erkan ME; Sager S; Halac M Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):62-3. PubMed ID: 23177348 [No Abstract] [Full Text] [Related]
40. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound. von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]